Style | Citing Format |
---|---|
MLA | Ghazimoradi MM, et al.. "The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-Based Approach Review." Current Pharmaceutical Design, vol. 28, no. 44, 2022, pp. 3572-3581. |
APA | Ghazimoradi MM, Azad FV, Jalali F, Kopaei MR (2022). The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-Based Approach Review. Current Pharmaceutical Design, 28(44), 3572-3581. |
Chicago | Ghazimoradi MM, Azad FV, Jalali F, Kopaei MR. "The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-Based Approach Review." Current Pharmaceutical Design 28, no. 44 (2022): 3572-3581. |
Harvard | Ghazimoradi MM et al. (2022) 'The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-Based Approach Review', Current Pharmaceutical Design, 28(44), pp. 3572-3581. |
Vancouver | Ghazimoradi MM, Azad FV, Jalali F, Kopaei MR. The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-Based Approach Review. Current Pharmaceutical Design. 2022;28(44):3572-3581. |
BibTex | @article{ author = {Ghazimoradi MM and Azad FV and Jalali F and Kopaei MR}, title = {The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-Based Approach Review}, journal = {Current Pharmaceutical Design}, volume = {28}, number = {44}, pages = {3572-3581}, year = {2022} } |
RIS | TY - JOUR AU - Ghazimoradi MM AU - Azad FV AU - Jalali F AU - Kopaei MR TI - The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-Based Approach Review JO - Current Pharmaceutical Design VL - 28 IS - 44 SP - 3572 EP - 3581 PY - 2022 ER - |